EC Inwald
- Cancer Research top 10%
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 2
- Oncology top 10%
- HER2/EGFR in Cancer Research 4
- Cancer survivorship and care 3
-
- Breast Lesions and Carcinomas 2
-
- Clinical practice guidelines implementation 2
-
- Economic and Financial Impacts of Cancer 2
-
- Estrogen and related hormone effects 1
EC Inwald
10 papers receiving 507 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 260
- Oncology 266
- Pathology and Forensic Medicine 109
- Radiology, Nuclear Medicine and Imaging 81
- Pulmonary and Respiratory Medicine 98
Countries citing papers authored by EC Inwald
This map shows the geographic impact of EC Inwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EC Inwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EC Inwald more than expected).
Fields of papers citing papers by EC Inwald
This network shows the impact of papers produced by EC Inwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EC Inwald. The network helps show where EC Inwald may publish in the future.
Co-authorship network
The 25 scholars most cited alongside EC Inwald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 1 | |
| 3 | 2019 | 5 | |
| 4 | 2018 | 5 | |
| 5 | 2017 | 26 | |
| 6 | 2016 | 6 | |
| 7 | 2015 | 10 | |
| 8 | 2014 | 0 | |
| 9 | 2014 | 1 | |
| 10 | 2014 | 28 | |
| 11 | Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registrybreakdown → | 2013 | 434 |
About EC Inwald
EC Inwald is a scholar working on Cancer Research, Oncology, Obstetrics and Gynecology, Reproductive Medicine and Pathology and Forensic Medicine, having authored 11 papers that have together received 517 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (4 papers), Cancer survivorship and care (3 papers), Clinical practice guidelines implementation (2 papers), Economic and Financial Impacts of Cancer (2 papers), Cancer Genomics and Diagnostics (2 papers), Breast Lesions and Carcinomas (2 papers) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Cancer Research (260 citations), Oncology (266 citations), Pathology and Forensic Medicine (109 citations), Radiology, Nuclear Medicine and Imaging (81 citations) and Pulmonary and Respiratory Medicine (98 citations). EC Inwald has collaborated with scholars based in Germany, Austria and Portugal. Frequent co-authors include Olaf Ortmann, Michael Koller, Monika Klinkhammer‐Schalke, Ferdinand Hofstädter, Florian Zeman, M Gerstenhauer, Gero Brockhoff, Matthias Evert, Stefanie Buchholz and Simone Wesselmann. Their work appears in journals such as Archives of Gynecology and Obstetrics, Breast Cancer Research and Treatment, Annals of Oncology, BioMed Research International and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.